BRD2 and Hodgkins lymphoma: As mentioned before, Loverro et al. found no significant difference in serum hormonal levels of FSH, inhibin B, AMH, and the number of antral follicle count (AFC) between the two groups of HL patients receiving or not the GnRHa cotreatment [37].